Engineered extracellular vesicles directed to the spike protein inhibit SARS-CoV-2

SARS-CoV-2 (CoV-2) viral infection results in COVID-19 disease, which has caused significant morbidity and mortality worldwide. A vaccine is crucial to curtail the spread of SARS-CoV-2, while therapeutics will be required to treat ongoing and reemerging infections of SARS-CoV-2 and COVID-19 disease....

Descripción completa

Detalles Bibliográficos
Autores principales: Scott, Tristan A., Supramaniam, Aroon, Idris, Adi, Cardoso, Angelo A., Shrivastava, Surya, Kelly, Gabrielle, Grepo, Nicole A., Soemardy, Citradewi, Ray, Roslyn M., McMillan, Nigel A.J., Morris, Kevin V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8806709/
https://www.ncbi.nlm.nih.gov/pubmed/35127966
http://dx.doi.org/10.1016/j.omtm.2022.01.015

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8806709/
https://www.ncbi.nlm.nih.gov/pubmed/35127966
http://dx.doi.org/10.1016/j.omtm.2022.01.015

Ejemplares similares